| Initial public offer of up to [*] equity shares of face value of Rs. 2 each ("Equity Shares") of Akums Drugs and Pharmaceuticals Limited ("Company" or "Issuer") for cash at a price of Rs. [*] per equity share (including a share premium of Rs. [*] per equity share) ("Offer Price") aggregating up to
Rs. [*] crores comprising a fresh issue of up to [*] equity shares aggregating up to Rs. 680.00 crores by the company ("Fresh Issue") and an offer for sale of up to 17,330,435 equity shares aggregating up to Rs. [*] crores ("Offered Shares") by the selling shareholders, comprising up to 1,512,000 equity shares aggregating up to Rs. [*] crores by Sanjeev Jain, up to 1,512,000 equity shares aggregating up to Rs. [*] crores by Sandeep Jain (together the "Promoter Selling Shareholders") and up to 14,306,435 equity shares aggregating up to Rs. [*] crores by Ruby QC Investment Holdings Pte. Ltd. (the "Investor Selling Shareholder") (the promoter selling shareholders and the investor selling shareholder, collectively referred to as the "Selling Shareholders") ("Offer for Sale", together with the fresh issue, the "Offer").
This offer includes a reservation of up to [*] equity shares aggregating up to Rs. 15.00 crores for subscription by eligible employees (the "Employee Reservation Portion"). The offer less the employee reservation portion is hereinafter referred to as the "Net Offer". The offer and the net offer will constitute [*]% and [*]% of its post-offer paid-up equity share capital, respectively.
Price Band: Rs. 646 to Rs. 679 per equity share of face value of Rs. 2 each.
The floor price is 323 times of tha face value of and tha cap price is
339.50 times of the face value.
Bid can be made for a minimum of 22 equity share and in multiples of 22 equity share thereafter.
A discount of Rs. 64 per equity share is being offred to eligible employee bidding in the employee reservation portion. |